Adalimumab Monotherapy vs Adalimumab With Methotrexate for Psoriasis

Zenas Z N Yiu; Catherine Smith; Philip Laws; Philip Hampton; Christopher Em Griffiths; Richard B. Warren

doi:10.1001/jamadermatol.2025.1463

Abstract

1 min read

The results of this cohort study suggest that there was no evidence of a difference in the effectiveness and persistence of adalimumab in people with psoriasis between monotherapy and adalimumab with concomitant methotrexate.

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article2023

004 Does methotrexate affect treatment persistence or effectiveness of adalimumab for psoriasis? A trial emulation cohort study

Zenas Z N Yiu, Catherine Smith, Philip Laws, Philip Hampton, Christopher Em Griffiths, Richard B. Warren

Article2008

Methotrexate for psoriasis in the era of biological therapy

Richard B. Warren, R.J.G. Chalmers, Christopher Em Griffiths, Alan Menter

Article1999

Combination treatment with methotrexate and cyclosporin for severe recalcitrant psoriasis

Clark, Kirby, M. A. Morris, Davison, Zaki, Emerson, Saihan, Chalmers, Juliet N. Barker, Allen, Christopher Em Griffiths

Article2009

Adalimumab for the treatment of psoriasis

Richard B. Warren, Christopher Em Griffiths

Article2018

Biological therapy for psoriasis and risk of cancer

I. García‐Doval, M.Á. Descalzo, Kimberly Mason, Adam D. Cohen, A.D. Ormerod, Francisco Gómez‐García, Simone Cazzaniga, Ilan Feldhamer, Hasan Ali, Enrique Herrera‐Acosta, Christopher Em Griffiths, Roni Stern, Luigi Naldi